P53 Sumoylation

P53 sumoylation is a post-translational modification in which small ubiquitin-like modifier (SUMO) proteins are covalently attached to the tumor suppressor p53, helping regulate its activity in response to cellular stress. The process uses an enzymatic cascade involving SUMO activation, conjugation, and E3 ligase-mediated transfer to specific lysine residues on p53, while SUMO proteases can reverse the modification. By altering p53 stability, subcellular localization, protein interactions, and transcriptional activity, sumoylation can influence cell-cycle arrest, DNA-damage responses, senescence, and apoptosis. Studying this regulatory pathway supports research into cancer biology and mechanisms that control p53-dependent tumor suppression.

P53 Sumoylation - Related Videos

Research

JoVE EoE - Assay Techniques

SUMOylation Assay: An In Vitro Technique to Detect the SUMOylation Status of Substrate Proteins by Immunoblotting

0 Views •

2025

This video demonstrates the in vitro method for SUMOylation of substrate proteins using a sequential enzyme cascade. Further, the SUMOylated status of the protein is identified using the electrophoresis and immunoblotting technique.

In Vivo Detection and Analysis of Rb Protein SUMOylation in Human Cells

0 Views •

Cited by 2 •

2017

Small ubiquitin-related modifier (SUMO) family proteins are conjugated to the lysine residues of target proteins to regulate various cellular processes. This paper describes a protocol for the detection of retinoblastoma (Rb) protein SUMOylation under endogenous and exogenous conditions in human cells.

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

0 Views •

2025

Hs578T breast cancer cells harboring the p53 V157F mutation exhibit significantly higher Thioflavin T fluorescence compared to MCF7 cells, indicating enhanced protein aggregation. Multipoint fluorescence measurements improve detection accuracy and reliability in identifying β-sheet-rich aggregates, underscoring the importance of aggregation-prone p53 mutations in cancer research and the development of therapeutic strategies.

Purification of Ubiquitinated p53 Proteins from Mammalian Cells

0 Views •

Cited by 1 •

2022

The protocol describes a step-by-step method to purify ubiquitinated proteins from mammalian cells using the p53 tumor suppressor protein as an example. Ubiquitinated p53 proteins were purified from cells under stringent nondenaturing and denaturing conditions.

In Vitro SUMOylation Assay to Study SUMO E3 Ligase Activity

0 Views •

Cited by 11 •

2018

Unlike ubiquitin ligases, few E3 SUMO ligases have been identified. This modified in vitro SUMOylation protocol is able to identify novel SUMO E3 ligases by an in vitro reconstitution assay.

View All Results

FAQs

Related Topics